Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Diepolder

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Der Internist|March 3, 2004
[Prevention and therapy of viral hepatitis]H M Diepolder
European Journal of Clinical Investigation|October 1, 1994
T cell recognition of hepatitis B and C viral antigensM C Jung, H M Diepolder, G R Pape
Journal of Viral Hepatitis|April 12, 2000
Role of the specific T-cell response for clearance and control of hepatitis C virusG R Pape, T J Gerlach, H M Diepolder, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 1996
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis CH M Diepolder, R Zachoval, R M Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 1997
Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis CS Kiefersauer, C Reiter, J Eisenburg, et al.
Journal of Virology|August 3, 2001
Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clonesH M Diepolder, N H Gruener, J T Gerlach, et al.
Transplantation|July 27, 2001
Alloreactivity of natural killer cells in allogeneic liver transplantationM Oertel, K Kohlhaw, H M Diepolder, et al.
Lancet (London, England)|October 14, 1995
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infectionH M Diepolder, R Zachoval, R M Hoffmann, et al.
Gut|May 17, 2008
The role of the novel Th17 cytokine IL-26 in intestinal inflammationJ Dambacher, F Beigel, K Zitzmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantationR M Hoffmann, C Günther, H M Diepolder, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Der Internist|March 3, 2004
[Prevention and therapy of viral hepatitis]H M Diepolder
European Journal of Clinical Investigation|October 1, 1994
T cell recognition of hepatitis B and C viral antigensM C Jung, H M Diepolder, G R Pape
Journal of Viral Hepatitis|April 12, 2000
Role of the specific T-cell response for clearance and control of hepatitis C virusG R Pape, T J Gerlach, H M Diepolder, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 1996
The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis CH M Diepolder, R Zachoval, R M Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 1997
Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis CS Kiefersauer, C Reiter, J Eisenburg, et al.
Journal of Virology|August 3, 2001
Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clonesH M Diepolder, N H Gruener, J T Gerlach, et al.
Transplantation|July 27, 2001
Alloreactivity of natural killer cells in allogeneic liver transplantationM Oertel, K Kohlhaw, H M Diepolder, et al.
Lancet (London, England)|October 14, 1995
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infectionH M Diepolder, R Zachoval, R M Hoffmann, et al.
Gut|May 17, 2008
The role of the novel Th17 cytokine IL-26 in intestinal inflammationJ Dambacher, F Beigel, K Zitzmann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantationR M Hoffmann, C Günther, H M Diepolder, et al.
Pageof 3